Literature DB >> 7876096

Transcriptional regulation of the carcinoembryonic antigen gene. Identification of regulatory elements and multiple nuclear factors.

W Hauck1, C P Stanners.   

Abstract

Human carcinoembryonic antigen (CEA) belongs to a family of membrane glycoproteins that are overexpressed in many carcinomas; CEA functions in vitro as a homotypic intercellular adhesion molecule and can inhibit differentiation when expressed ectopically in myoblasts. The regulation of expression of CEA is therefore of considerable interest. The CEA gene promoter region between -403 and -124 base pairs upstream of the translation initiation site directed high levels of expression in CEA-expression SW403 cells and was 3 times more active in differentiated than in undifferentiated Caco-2 cells, correlating exactly with the 3-fold increase in CEA mRNA seen in differentiated Caco-2 cells. Inclusion of additional upstream sequences between -1098 and -403 base pairs repressed all activity. By in vitro footprinting and deletion analyses, four cis-acting elements were mapped within the positive regulatory region, and one element within the silencing region. Several nuclear factors binding to these domains were identified: USF, Sp1, and an Sp1-like factor. By co-transfection, USF directly activated the CEA gene promoter in vivo in both SW403 and Caco-2 cells. In addition, the levels of factors binding to each positively acting element increased dramatically with differentiation in Caco-2 cells. Thus the transcriptional control of the CEA gene depends on the interaction of several regulatory elements that bind multiple specific factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876096     DOI: 10.1074/jbc.270.8.3602

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Identification and characterization of the potential promoter regions of 1031 kinds of human genes.

Authors:  Y Suzuki; T Tsunoda; J Sese; H Taira; J Mizushima-Sugano; H Hata; T Ota; T Isogai; T Tanaka; Y Nakamura; A Suyama; Y Sakaki; S Morishita; K Okubo; S Sugano
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy.

Authors:  Jing Jia; Shuzhi Zhang; Zhenyu Jia; Jiang Cao
Journal:  Cancer Gene Ther       Date:  2019-05-27       Impact factor: 5.987

3.  Elevation of carcinoembryonic antigen coinciding with disease activity of ulcerative colitis.

Authors:  Sayaka Yamaguchi; Yoshiaki Takeuchi; Katsuhito Arai; Chitose Oishi; Tomoko Norose; Toshiko Yamochi-Onizuka; Miki Kushima; Hidekazu Ota; Michio Imawari
Journal:  Clin J Gastroenterol       Date:  2012-02-12

Review 4.  Molecular chemotherapy for breast cancer.

Authors:  A Patterson; A L Harris
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

5.  Regulation of carcinoembryonic antigen expression in human colon carcinoma cells by the organ microenvironment.

Authors:  Y Kitadai; R Radinsky; C D Bucana; Y Takahashi; K Xie; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

6.  Ribozyme as an approach for growth suppression of human pancreatic cancer.

Authors:  H Kijima; K J Scanlon
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

7.  Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor.

Authors:  I Castagliuolo; O Morteau; A C Keates; L Valenick; C-C Wang; J Zacks; B Lu; N P Gerard; C Pothoulakis
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.

Authors:  A Couvineau; J J Maoret; C Rouyer-Fessard; I Carrero; M Laburthe
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

9.  Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis.

Authors:  Jin C Kim; Seon A Roh; Hee C Kim; Kum H Koo; Young K Cho; Chang S Yu; Young M Kwon; Jung S Kim
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

10.  Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells.

Authors:  Satoshi Okabe; Takehiro Arai; Hironori Yamashita; Kenichi Sugihara
Journal:  J Cancer Res Clin Oncol       Date:  2003-06-03       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.